Trial Profile
An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of streptococcus pneumoniae in patients with acute exacerbation of chronic bronchitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary) ; Azithromycin; Cefuroxime
- Indications Acute exacerbations of chronic bronchitis; Streptococcal infections
- Focus Therapeutic Use
- Acronyms PERSPECTIVE
- Sponsors Sanofi
- 07 Jun 2011 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 17 Oct 2006 Status change
- 13 Jan 2006 New trial record.